Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Current Approaches to Identify and Evaluate Cancer Biomarkers for Patient Stratification
by
Laversin, Stephanie
, Rees, Robert
, Murray, Cliff
, Ball, Graham
in
bioinformatics
/ biomarkers
/ breast cancer
/ genomics
/ patient stratification
/ personalized medicine
/ proteomics
2012
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Current Approaches to Identify and Evaluate Cancer Biomarkers for Patient Stratification
by
Laversin, Stephanie
, Rees, Robert
, Murray, Cliff
, Ball, Graham
in
bioinformatics
/ biomarkers
/ breast cancer
/ genomics
/ patient stratification
/ personalized medicine
/ proteomics
2012
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Current Approaches to Identify and Evaluate Cancer Biomarkers for Patient Stratification
Book Chapter
Current Approaches to Identify and Evaluate Cancer Biomarkers for Patient Stratification
2012
Request Book From Autostore
and Choose the Collection Method
Overview
The requirement for more effective treatments for cancer is highlighted by the failure rate of many therapies, thereby necessitating more “targeted” approaches, based on an understanding of the molecular features of the individual cancer and patient status at time of diagnosis and treatment. Whether treatment is based on surgery, radiotherapy, or chemotherapy, or gene or immunotherapy, a proportion of patients will fail to respond and progress their disease. In this review we have focused on breast cancer as a heterogeneous disease where a need to stratify “low” from “high” risk patients and therapy “responders” from “nonresponders” is apparent. The application of high‐throughput technologies results in a complexity of molecular features that requires bioinformatic data mining to identify important genotypic and proteomic traits associated with clinical utility. The potential combination of “omic” platforms provides an attractive means of gaining knowledge of the main characteristics associated with patient status.
Publisher
Wiley‐Blackwell
Subject
ISBN
9781405185745, 1405185740
MBRLCatalogueRelatedBooks
Related Items
Related Items
We currently cannot retrieve any items related to this title. Kindly check back at a later time.
This website uses cookies to ensure you get the best experience on our website.